HRT Financial’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

HRT Financial’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,718	Closed	-$23K	–	3335
2024 Q1	$23K	Buy	+2,718	New	+$13K	﹤0.01%	2002
2023 Q3	–	Sell	-2,458	Closed	-$14K	–	3299
2023 Q2	$14K	Buy	+2,458	New	+$44.9K	﹤0.01%	2144

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

HRT Financial's TCON Position: Q2 2024 in Review

HRT Financial sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 2,718 shares — an estimated $23K sold.

HRT Financial first reported a position in TCON in Q2 2023 and held it in 2 quarters. The position peaked at $23K in Q1 2024. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

HRT Financial reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
HRT Financial sold 2,718 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $23K.
HRT Financial first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
HRT Financial's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $23K in Q1 2024.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.